Qiagen NV

US · QGEN #1551 by market cap Listed 1970

44.79 -0.86 -1.88%

Live - 5344 symbols - heartbeat 71s ago · 2026-10-08 08:13

Pre-market 44.34 -1.00%

After-hours 44.79 0.00%

Overnight 44.75 -0.09%

Market cap: 9.25B
P/E (TTM): 22.77
P/B: 2.75
EPS: 1.94
Div yield: 0.78%
52W pos: 50%

Reader sentiment Are you bullish or bearish on QGEN?

Anonymous reader poll. Unscientific, not investment advice.

About Qiagen NV

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.

Founded: 1996
CEO: Mr. Thierry Bernard
Employees: 5,654
Headquarters: Venlo, Limburg, Netherlands (the)
Fiscal year end: 12-31
Website: qiagen.com

Company profile

Exchange: US
Symbol: QGEN
Market-cap rank: #1551
Listing date: 1970-01-01
Market cap: 9.25B
Float cap: 9.19B
Shares out: 206.50M
Float shares: 205.17M

Sectors & themes

Diagnostics & Research Fractional Shares JP

Browse all sectors & themes

Quote time 2026-10-08 08:13:50 · For reference only, not investment advice and not tailored to your situation.